AMLX
NASDAQ · Pharmaceuticals
Amylyx Pharmaceuticals Inc
$22.82
-1.37 (-5.66%)
Open$24.19
Previous Close$24.19
Day High$24.60
Day Low$22.56
52W High$24.36
52W Low$7.48
Volume—
Avg Volume2.55M
Market Cap2.54B
P/E Ratio—
EPS$-1.51
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+62.8% upside
Current
$22.82
$22.82
Target
$37.15
$37.15
$28.49
$37.15 avg
$49.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 140.51M | 449.35M | 403.13M |
| Net Income | -485,264,659 | 64.17M | 62.78M |
| Profit Margin | -345.4% | 14.3% | 15.6% |
| EBITDA | -506,644,708 | 107.91M | 96.37M |
| Free Cash Flow | — | 81.20M | 53.03M |
| Rev Growth | +574.3% | +13.9% | +9.9% |
| Debt/Equity | — | 0.29 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |